Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2025 04:00 ET | Source: AKAMPION

tiakis Biotech Successfully Completes Data Package to Advance Tiprelestat into Phase II clinical trial in PAH

6-month GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to be initiated by Stanford University in mid-2026 Kiel, GERMANY,...